Virtus Family Office’s ResMed RMD Stock Holding History

Virtus Family Office’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.68M	Buy	8,634 +1,629	+23%	+$338K	1.33%	32
2026 Q1	$1.57M	Buy	+7,005	New	+$1.75M	1.34%	31

Other funds holding RMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Virtus Family Office's RMD Position: Q2 2026 in Review

Virtus Family Office increased its ResMed (RMD) stake by 23% in Q2 2026, buying an estimated $338K and bringing the position to 8,634 shares worth $1.68M. The position accounts for 1.33% of the portfolio, ranked #32.

Virtus Family Office first reported a position in RMD in Q1 2026 and has held it in 2 quarters since. 889 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

Virtus Family Office held 8,634 shares of ResMed worth $1.68M as of Q2 2026.
Virtus Family Office bought 1,629 ResMed shares in Q2 2026, an estimated $338K.
ResMed made up 1.33% of Virtus Family Office's portfolio in Q2 2026, its #32 holding.
Virtus Family Office first reported a position in ResMed in Q1 2026 and has held it in 2 quarters since.
889 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Virtus Family Office's 13F filing for Q2 2026, filed 4 Aug 2026.